Effects of penetration enhancers on in vitro permeability of meloxicam gels

International Journal of Pharmaceutics

Volumn 343, Issue 1-2, 2007, Pages 26-33

  Jantharaprapap, R ^a   Stagni, G ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

HPLC; Human cadaver skin; Meloxicam; Menthol; Skin permeability

Indexed keywords

ALCOHOL; CELLULOSE; DIMETHYL SULFOXIDE; GLYCOL; HYDROXYPROPYLCELLULOSE; MACROGOL 400; MELOXICAM; MENTHOL; MYRISTIC ACID ISOPROPYL ESTER; OLEIC ACID; PENETRATION ENHANCING AGENT; POLYSORBATE 20; PROPYLENE GLYCOL; WATER;

ARTICLE; CADAVER; CELL MEMBRANE; DERMIS; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; GEL; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; SKIN PERMEABILITY; STATISTICAL SIGNIFICANCE; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLULOSE; DIMETHYL SULFOXIDE; ETHANOL; GELS; HUMANS; MEMBRANES, ARTIFICIAL; MENTHOL; MYRISTATES; OLEIC ACID; PERMEABILITY; POLYETHYLENE GLYCOLS; POLYSORBATES; PROPYLENE GLYCOL; SKIN ABSORPTION; SOLVENTS; THIAZINES; THIAZOLES; WATER;

EID: 34548258890     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.04.011     Document Type: Article

References (30)

1. Addicks W.J., Weiner N.D., Curl R.L., and Flynn G.L. Drug delivery from topical formulations: theoretical prediction and experimental assessment. Topical Drug Delivery Formulations (1990), Dekker, New York
2. Aungst B.J. Fatty acids as skin permeation enhancers. Percutaneous Penetration Enhancers. first ed. (1995), CRC Press, Boca Raton
3. Babar A., Solanki U.D., Cutie A.J., and Plakogiannis F. Piroxicam release from different dermatological bases: in-vitro studies using cellulose membrane and hairless mouse skin. Drug. Dev. Ind. Pharm. 16 (1990) 523-540
4. Beetge E., du Plessis J., Muller D.G., Goosen C., and van Rensburg F.J. The influence of the physicochemical characteristics and pharmacokinetic properties of selected nsaid's on their transdermal absorption. Int. J. Pharm. 193 (2000) 261-264
5. Choi, H.K., 2005. Effect of salt formation with ethanolamine on the percutaneous absorption of meloxicam. AAPS J., Nashville, TN.
6. Engelhardt G., Homma D., Schlegel K., Utzmann R., and Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm. Res. 44 (1995) 423-433
7. Francoeur M.L., Golden G.M., and Potts R.O. Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 7 (1990) 621-627
8. Franz T.J., Lehman P.A., and Kagyand M.K. Dimethylsulfoxide. Percutaneous Penetration Enhancers. first ed. (1995), CRC Press, Boca Raton
9. Hashida M., and Yamashita F. Terpenes as penetration enhancers. Percutaneous Penetration Enhancers. first ed. (1995), CRC Press, Boca Raton
10. Higuchi W.I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51 (1962) 802-804
11. Kobayashi D., Matsuzawa T., Sugibayashi K., Morimoto Y., and Kimura M. Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model. Pharm. Res. 11 (1994) 96-103
12. Komatsu H., and Suzuki M. Percutaneous absorption of butylparaben through guinea pig skin in vitro. J. Pharm. Sci. 68 (1979) 596-598
13. Kunta J.R., Goskonda V.R., Brotherton H.O., Khan M.A., and Reddy I.K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 86 (1997) 1369-1373
14. McVean M., and Liebler D.C. Inhibition of uvb induced DNA photodamage in mouse epidermis by topically applied alpha-tocopherol. Carcinogenesis 18 (1997) 1617-1622
15. Mortazavi S.A., and Aboofazeli R. An investigation into the effect of various penetration enhancers on percutaneous absorption of piroxicam. Iranian J. Pharm. Res. (2003) 135-140
16. Naik A., Pechtold L.A., Potts R.O., and Guy R.H. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J. Controlled Release 37 (1995) 299-306
17. Noble S., and Balfour J.A. Meloxicam. Drugs 51 (1996) 424-432
18. O'Hanlon J.J., McCleane G., and Muldoon T. Preoperative application of piroxicam gel compared to a local anaesthetic field block for postoperative analgesia. Acta Anaesthesiol. Scand. 40 (1996) 715-718
19. Parikh D.K., and Ghosh T.K. Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech 6 (2005) E144-E149
20. Penzes T., Blazso G., Aigner Z., Falkay G., and Eros I. Topical absorption of piroxicam from organogels-in vitro and in vivo correlations. Int. J. Pharm. 298 (2005) 47-54
21. Ranade V.V. Drug delivery systems. 6. Transdermal drug delivery. J. Clin. Pharmacol. 31 (1991) 401-418
22. Reddy L.H., and Ghosh B. Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin. Indian J. Exp. Biol. 39 (2001) 47-51
23. Remane Y., Leopold C.S., and Maibach H.I. Percutaneous penetration of methyl nicotinate from ointments using the laser doppler technique: bioequivalence and enhancer effects. J. Pharmacokinet. Pharmacodyn. 33 (2006) 719-735
24. Ritschel W.A., and Kearns G.L. Appendix: pharmacokinetics parameters of important drugs. Handbook of Basic Pharmacokinetics Including Clinical Application. sixth ed. (2004), American Pharmacist Association, Washington, DC
25. Santoyo S., Arellano A., Ygartua P., and Martin C. Penetration enhancer effects on the vitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm. 117 (1995) 219-224
26. Seedher N., and Bhatia S. Solubility enhancement of cox-2 inhibitors using various solvent systems. AAPS PharmSciTech 4 (2003) E33
27. Shargel L., Wu-Pong S., and Yu A.B.C. Multiple-dosage regimens. Applied Biopharmaceutics & Pharmacokinetics. fifth ed. (2005), McGraw-Hill, New York, NY
28. Suwanpidokkul N., Thongnopnua P., and Umprayn K. Transdermal delivery of zidovudine (azt): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS PharmSciTech 5 (2004) 48
29. Walters K.A. Penetration enhancers and their use in transdermal therapeutic system. Transdermal Drug Delivery Developmental Issues and Research (1989), Dekker, New York
30. Whitehouse M.W., and Roberts M.S. Drugs for pain and inflammation. Dermal Absorption and Toxicity Assessment (1998), Dekker, New York